Related Experiment Video
Updated: May 8, 2026

Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Published on: June 25, 2015
Tunable TriPcides suppress virulence factor secretion during Staphylococcus aureus infection and kill dormant cells
Hasan Tükenmez1,2, Taylor M Nye3, Pardeep Singh4
1Nordic BioConsult AB, SE-91332, Holmsund, Sweden.
Abstract:
Antimicrobial resistance (AMR) in common bacterial pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), is an increasingly dire public health threat, with MRSA accounting for up to 90% of S. aureus infections. To expand the treatment arsenal against MRSA infections, we developed a class of tunable three-dimensional tricyclic 2-pyridones, termed TriPcides, that can kill MRSA resistant to last-resort antibiotics and eliminate MRSA persister cells. No preexisting resistance was detected across hundreds of clinical isolates, and continuous exposure of MRSA to TriPcides did not elicit detectable resistance. Treatment with TriPcides causes a rapid decrease in membrane integrity and increased levels of reactive oxygen species. Last, TriPcides effectively reduce secretion of important virulence factors and result in reduced ulcer size and healing time in S. aureus murine skin and soft tissue infections but do not reduce bacterial burden.
Insights
New TriPcides combat antibiotic-resistant bacteria like methicillin-resistant Staphylococcus aureus (MRSA). These compounds kill resistant MRSA and persister cells without inducing resistance, offering a promising new treatment avenue.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Antimicrobial resistance (AMR) is a major global health crisis.
- Methicillin-resistant Staphylococcus aureus (MRSA) causes a significant portion of S. aureus infections.
- Existing treatments are becoming less effective against resistant bacterial strains.
Purpose of the Study:
- To develop novel therapeutic agents against MRSA.
- To identify compounds effective against antibiotic-resistant and persister MRSA cells.
- To evaluate the mechanism of action and in vivo efficacy of new compounds.
Main Methods:
- Synthesis and characterization of a novel class of tunable three-dimensional tricyclic 2-pyridones (TriPcides).
- Testing TriPcides against clinical isolates of MRSA, including those resistant to last-resort antibiotics.
- Assessing MRSA resistance development through continuous exposure experiments.
- Investigating the mode of action, including effects on membrane integrity and reactive oxygen species (ROS) levels.
- Evaluating TriPcides in a murine model of S. aureus skin and soft tissue infection.
Main Results:
- TriPcides demonstrated potent activity against MRSA, including strains resistant to conventional antibiotics.
- No pre-existing or induced resistance to TriPcides was observed in MRSA isolates.
- Treatment with TriPcides led to rapid loss of membrane integrity and increased ROS production.
- TriPcides reduced virulence factor secretion and improved healing in a murine infection model, without reducing bacterial load.
Conclusions:
- TriPcides represent a novel class of compounds effective against challenging MRSA infections.
- These compounds offer a new strategy to combat AMR by targeting resistant and persister MRSA cells.
- Further investigation into TriPcides is warranted for their potential clinical application in treating S. aureus infections.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Regulation of Bacterial Virulence
Clinical Significance of Antibiotic Resistance
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Inhibitors of Bacterial Protein Synthesis

